TDAC
Translational Development Acquisition Corp. Ordinary Shares
NASDAQ: TDAC · FINANCIAL SERVICES · SHELL COMPANIES
$10.85
+0.09% today
Updated 2026-10-28
Market cap
$209.50M
P/E ratio
41.73
P/S ratio
—
EPS (TTM)
$0.26
Dividend yield
—
52W range
$10 – $11
Volume
0.0M
Translational Development Acquisition Corp. Ordinary Shares (TDAC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$10.85
12-Month target
$6.60
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.